1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. THERAVANCE BIOPHARMA INC
Theravance Biopharma Inc XNAS: TBPH

Theravance Biopharma Inc Live Stock Price Today, Share Analysis and Chart

Turnaround Potential
about

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient...

Read More
18.12 -0.43 (-2.32%)
129.37% Gain from 52W Low
303.0K
XNAS Volume

XNAS 08 Dec, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
44.4 / 100
Valuation Score
Mid Valuation
34.5 / 100
Momentum Score
Technically Moderately Bullish
66.8 / 100
Turnaround Potential These stocks may be affordable or expensive due to their medium quality and a good technical scoring. However, their reasonable financials successfully attract investors. View Similar Embed DVM
Analyst Price Target
27
1Yr Price target upside is 47%
7 analysts

14

S

11

W

4

O

1

T

SWOT Analysis

Theravance Biopharma Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..